MoonLake Immunotherapeutics (MLTX)
14.07
-0.54
(-3.70%)
USD |
NASDAQ |
Dec 11, 16:00
14.06
-0.02
(-0.11%)
After-Hours: 20:00
MoonLake Immunotherapeutics EPS Diluted (Quarterly): -1.100 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Baxter International, Inc. | 0.0175 |
| aTyr Pharma, Inc. | -0.265 |
| BeOne Medicines Ltd. | 1.092 |
| Merus NV | -1.262 |
| AC Immune SA | -0.1964 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -70.69M |
| Total Expenses (Quarterly) | 69.73M |
| Enterprise Value | 694.35M |
| Earnings Yield | -23.65% |
| Normalized Earnings Yield | -23.65 |